 Saint- Herb lain Franc e , September 14 , 2021 Valneva SE, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in Valnevas Phase 3 trial, VLA2001-304, of its inactivated COVID-19 vaccine candidate, VLA2001. 